Literature DB >> 8173777

Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma.

T Yano1, Y Ichikawa, S Komatu, S Arai, K Oizumi.   

Abstract

Although mycoplasmal airway infection frequently exacerbates bronchial asthma, the cause of the initial onset of asthma remains unclear at present. In this report, we describe a patient in whom a previous acute mycoplasmal respiratory infection led to an initial onset of bronchial asthma. One month after the onset of the illness, cough and wheezing appeared. Pulmonary function studies revealed an airway obstructive dysfunction. Oral administration of bronchodilators resulted in a marked improvement of the asthmatic symptoms. An airway hyperresponsiveness to methacholine was demonstrated even 2 yrs after the initial onset of the illness, and IgE antibody specific to Mycoplasma pneumoniae was detected in the serum by use of enzyme-linked immunosorbent assay. An immediate skin test for M. pneumoniae was positive in addition to multiple positive skin tests. A bronchial inhalation challenge test with M. pneumoniae antigen also yielded a positive result. We conclude that the effects of mycoplasmal respiratory infections on the airway are multifactorial and involve a complex interplay of airway inflammation and IgE-mediated hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8173777     DOI: 10.1164/ajrccm.149.5.8173777

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  31 in total

1.  Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Authors:  T R Kannan; Jacqueline J Coalson; Marianna Cagle; Oxana Musatovova; R Doug Hardy; Joel B Baseman
Journal:  J Infect Dis       Date:  2011-09-28       Impact factor: 5.226

Review 2.  Lymphatics in lung disease.

Authors:  Souheil El-Chemaly; Stewart J Levine; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

3.  Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.

Authors:  Jay Peters; Harjinder Singh; Edward G Brooks; Joseph Diaz; Thirumalai R Kannan; Jacqueline J Coalson; Janet G Baseman; Marianna Cagle; Joel B Baseman
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

4.  The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Authors:  Diego J Maselli; Jorge L Medina; Edward G Brooks; Jacqueline J Coalson; Thirumalai R Kannan; Vicki T Winter; Molly Principe; Marianna P Cagle; Joel B Baseman; Peter H Dube; Jay I Peters
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

5.  Mast cells protect mice from Mycoplasma pneumonia.

Authors:  Xiang Xu; Dongji Zhang; Natalya Lyubynska; Paul J Wolters; Nigel P Killeen; Peter Baluk; Donald M McDonald; Samuel Hawgood; George H Caughey
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

6.  Mycoplasma pneumoniae in children with acute and refractory asthma.

Authors:  Pamela R Wood; Vanessa L Hill; Margaret L Burks; Jay I Peters; Harjinder Singh; Thirumalai R Kannan; Shruthi Vale; Marianna P Cagle; Molly F R Principe; Joel B Baseman; Edward G Brooks
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02-23       Impact factor: 6.347

7.  Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.

Authors:  Seoung-Ju Park; Yong-Chul Lee; Yang-Keun Rhee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

8.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 9.  Asthma microbiome studies and the potential for new therapeutic strategies.

Authors:  Yvonne J Huang
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

10.  Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis.

Authors:  Xiang Xu; John Greenland; Peter Baluk; Alicia Adams; Oishee Bose; Donald M McDonald; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.